![Charles Kunsch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Kunsch
Director/Board Member at Firecyte Therapeutics, Inc.
Network origin in Charles Kunsch first degree
Entity | Entity type | Industry | |
---|---|---|---|
Firecyte Therapeutics, Inc.
![]() Firecyte Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Firecyte Therapeutics, Inc. is an emerging biotechnology company based in Cambridge, MA that is focused on developing novel treatment strategies for progressive neurodegenerative diseases of the eye. The company's research is centered around the role of microglia and neuroinflammation in these diseases. The team is led by Jonathan Levenson, the Chief Scientific Officer, who has over 16 years of experience in neuropsychiatry, neurodegeneration, and neuroinflammation. The company was founded by Dong Feng Chen and William E. Yelle, who has been the CEO since incorporation.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Charles Kunsch via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Sumitomo Pharma America, Inc.
![]() Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
![]() Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bracebridge Capital LLC
![]() Bracebridge Capital LLC Investment ManagersFinance Bracebridge Capital LLC (Bracebridge) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded in 1994 by Nancy Zimmerman and Gabriel Sunshine. They are owned by Bracebridge Capital II LP. Bracebridge provides investment advisory services to pooled investment vehicles. | Investment Managers | Private Equity Investor | |
Violet Therapeutics
![]() Violet Therapeutics Medical/Nursing ServicesHealth Services Violet Therapeutics is an American healthcare company founded by Meredith Fisher. Meredith Fisher has been the CEO since incorporation. | Medical/Nursing Services | Founder | |
Nocion Therapeutics, Inc.
![]() Nocion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Mass General Brigham Ventures LLC
![]() Mass General Brigham Ventures LLC Investment ManagersFinance Mass General Brigham Ventures LLC (Mass General Brigham Ventures) is a venture capital subsidiary of Partners Research Ventures & Licensing founded in 2005. The firm is headquartered in the Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Mediar Therapeutics, Inc.
![]() Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
Mount Holyoke College | College/University | Undergraduate Degree | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Massachusetts Institute of Technology | College/University | Masters Business Admin | |
Enlight Biosciences LLC
![]() Enlight Biosciences LLC Pharmaceuticals: MajorHealth Technology Enlight Biosciences LLC develops research tools for drug discovery and development. It offers patient-centric platforms that may impact all aspects of the connected health ecosystem from patient engagement and experience, to patient-focused research and development. The company was founded by Raju S. Kucherlapati, David Steinberg, Rakesh Kumar Jain, H. Robert Horbitz, and Sanjiv Sam Gambhir in July 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Envisia Therapeutics, Inc.
![]() Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Biotechnology | Chairman | |
University of Massachusetts | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Graduate Degree | |
Columbia Business School | College/University | Masters Business Admin | |
Takeda Digital Ventures
![]() Takeda Digital Ventures Investment ManagersFinance Takeda Digital Ventures (Takeda Digital Ventures) is a venture capital subsidiary of Takeda Pharmaceutical Co., Ltd. founded in 2018. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Director/Board Member |
Statistics
International
United States | 19 |
Sectoral
Health Technology | 9 |
Consumer Services | 6 |
Finance | 5 |
Health Services | 2 |
Operational
Director/Board Member | 8 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 4 |
Masters Business Admin | 2 |
Undergraduate Degree | 2 |
Most connected contacts
Insiders | |
---|---|
Meredith Fisher | 13 |
William E. Yelle | 7 |
Ruoxi Hu | 1 |
- Stock Market
- Insiders
- Charles Kunsch
- Company connections